Multiple Sclerosis Trial, Recruiting (NCT05819008)

Multiple Sclerosis Trial, Recruiting NCT05819008 Sponsor: Umeå University Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT05819008 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older
People who have been diagnosed with a neurological condition or injury, or who are currently being assessed by a doctor for such a diagnosis
People who own and are able to use a computer with an internet connection

Who may not be able to join:

People who have a severe psychiatric condition, such as schizophrenia or severe depression
People who have an addiction to alcohol or other substances
People who are not Swedish speakers
People who are currently taking sedative medications, such as sleep aids or certain pain medications
People who have more than one neurological diagnosis
People who are unable to take part in a neuropsychological assessment, or who are unable to give informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nils Berginström, PhD, Umeå Universitet, Department of Psychology

Phone: +46(0)90-786 88 64

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05819008

Sponsor: Umeå University

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: +46(0)90-786 88 64

More information: https://clinicaltrials.gov/study/NCT05819008

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older
People who have been diagnosed with a neurological condition or injury, or who are currently being assessed by a doctor for such a diagnosis
People who own and are able to use a computer with an internet connection

Who may not be able to join:

People who have a severe psychiatric condition, such as schizophrenia or severe depression
People who have an addiction to alcohol or other substances
People who are not Swedish speakers
People who are currently taking sedative medications, such as sleep aids or certain pain medications
People who have more than one neurological diagnosis
People who are unable to take part in a neuropsychological assessment, or who are unable to give informed consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Umeå University

Registry

ClinicalTrials.gov

Start date

10 March 2023

Est. completion

31 December 2027

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Validity of Rey Auditory Verbal Learning Test in Mindmore; Validity of Symbol Digit Processing Test in Mindmore; Validity of Corsi Block Test in Mindmore; Validity of Trail Making Test - Click in Mindmore; Validity of Stroop in Mindmore; Validity of FAS in Mindmore

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov